MINAPHARM PHARMACEUTICALS SAE EGX:MIPH:
MINAPHARM PHARMACEUTICALS Q3 CONSOL NET PROFIT ATTRIBUTABLE EGP 16.8 MILLION
MINAPHARM PHARMACEUTICALS Q3 CONSOL REVENUE EGP 1.50 BILLION
MINAPHARM PHARMACEUTICALS SAE EGX:MIPH:
MINAPHARM PHARMACEUTICALS Q3 CONSOL NET PROFIT ATTRIBUTABLE EGP 16.8 MILLION
MINAPHARM PHARMACEUTICALS Q3 CONSOL REVENUE EGP 1.50 BILLION